NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
0.970
+0.020 (2.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
NextCure Market Cap
NextCure has a market cap or net worth of $27.17 million as of December 20, 2024. Its market cap has decreased by -22.11% in one year.
Market Cap
27.17M
Enterprise Value
-42.02M
1-Year Change
-22.11%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $27.17M, a decrease of -93.78%. That is a compound annual growth rate of -38.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 27.17M | -14.60% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | 1.55B | 254.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 27.84M |
| Anebulo Pharmaceuticals | 27.75M |
| Forte Biosciences | 27.35M |
| KALA BIO | 27.32M |
| Enlivex Therapeutics | 27.05M |
| Curis | 26.87M |
| Cognition Therapeutics | 26.34M |
| BriaCell Therapeutics | 26.17M |